Trust and anxiety as primary drivers of digital health acceptance in multiple sclerosis: toward an extended disease-specific technology acceptance model

• by Felix Höpfl, Mira Brundiers

• March 13, 2026

Non-Linear Measures of Movement Variability in Multiple Sclerosis: A Clinical Narrative Review of Lyapunov Exponent and Entropy Applications in Balance and Gait

• by Banakheiri, Tina , Panisset, Maya G., Galea, Mary P., Cofré Lizama, L. Eduardo

• May 12, 2026

Integrative Machine Learning Approaches for Differentiating Pediatric Multiple Sclerosis from Non-Inflammatory Disorders via Optical Coherence Tomography

• by Chaojun Chen, Sahar Soltanieh, Sajith Rajapaksa, Farzad Khalvati, E. Ann Yeh

• April 21, 2026

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.

• by Kathryn Wighton

• April 20, 2026

• 2 min